Fiduciary Trust International of Pennsylvania’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-202,100	Closed	-$1.65M	–	345
2018 Q3	$1.65M	Buy	202,100 +30,000	+17%	+$230K	0.07%	193
2018 Q2	$1.68M	Sell	172,100 -13,000	-7%	-$133K	0.08%	189
2018 Q1	$1.61M	Buy	185,100 +800	+0.4%	+$8.63K	0.07%	203
2017 Q4	$2.31M	Buy	184,300 +2,200	+1%	+$25.2K	0.1%	183
2017 Q3	$1.52M	Buy	182,100 +42,650	+31%	+$451K	0.07%	183
2017 Q2	$2.37M	Buy	+139,450	New	+$2.77M	0.12%	175

Other funds holding ZYNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Campbell Capital Management Miami, Florida $279M AUM 49.18% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's ZYNE Position: Q4 2018 in Review

Fiduciary Trust International of Pennsylvania sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2018, closing a stake of 202,100 shares — an estimated $1.65M sold.

Fiduciary Trust International of Pennsylvania first reported a position in ZYNE in Q2 2017 and held it in 6 quarters. The position peaked at $2.37M in Q2 2017. 62 funds tracked by Wall St. Rank hold ZYNE as of Q4 2018.

Fiduciary Trust International of Pennsylvania reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2018 after selling out during the quarter.
Fiduciary Trust International of Pennsylvania sold 202,100 Zynerba Pharmaceuticals, Inc shares in Q4 2018, an estimated $1.65M.
Fiduciary Trust International of Pennsylvania first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2017 and held it in 6 quarters.
Fiduciary Trust International of Pennsylvania's Zynerba Pharmaceuticals, Inc position peaked at $2.37M in Q2 2017.
62 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2018.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2018, filed 14 Jan 2019.